openPR Logo
Press release

Global Neuropathic Pain Market is Appraised to be Valued US$ 8.3 Bn by 2024 End

11-16-2017 06:35 AM CET | Health & Medicine

Press release from: Persistence Market Resarch

Global Neuropathic Pain Market is Appraised to be Valued US$ 8.3

According to the latest market report published by Persistence Market Research titled ‘Global Market Study on Neuropathic Pain: Anticonvulsants Drug Class Segment Projected to Witness the Highest Growth Through 2024’, the global neuropathic pain market was valued at US$ 5.2 Bn in 2015 and is estimated to reach a market valuation of US$ 5.4 Bn by 2016. The market is projected to expand at a CAGR of 5.6% during an eight-year forecast period 2016–2024 and reach US$ 8.3 Bn by the end of 2024.

Request Sample Report@ https://www.persistencemarketresearch.com/samples/4149

Rising occurrence of diabetes and cancer, new treatment options to treat neuropathic pain, growth in the number of pain management centers, and increasing demand for neuropathic pain treatment are major factors driving revenue growth of the global neuropathic pain market currently. Other factors driving market growth include rapid product launches for the treatment of neuropathic pain, a growing awareness among patients for the treatment of neuropathic pain, and an increasing demand for generic drugs.

Pharmaceutical companies are focusing on developing new and improved drugs to fulfil unmet needs of patients suffering from neuropathic pain. However, challenges such as severe side effects of opioids and steroids and rising costs of branded drugs are likely to restrain the growth of the global neuropathic pain market in the next eight years.

The global neuropathic pain market is segmented on the basis of drug class, indication, and distribution channel. On the basis of drug class, the market has been segmented into Tricyclic Antidepressant, Anticonvulsants, Local Anaesthesia, Opioids, Steroids, and Others. The Anticonvulsants drug class segment is expected to remain the largest segment in the global neuropathic pain market, registering a CAGR of 6.4% in terms of value over the forecast period. The less side effects of this drug is expected to contribute to its growing popularity. The Anticonvulsants segment is projected to reach a market valuation of US$ 3.3 Bn by 2024 end. The Tricyclic Antidepressant segment is also likely to emerge as the most preferred drug class type for both patients and physicians globally over the forecast period.

On the basis of indication, the market has been segmented into Diabetic Neuropathy, Chemotherapy Induced Peripheral Neuropathy, and Others. The highest market share is held by the Diabetic Neuropathy segment, followed by the Chemotherapy Induced Peripheral Neuropathy segment. The Diabetic Neuropathy segment is estimated to account for the highest value share of 46.7% of the global neuropathic pain market by 2016 end. The Chemotherapy Induced Peripheral Neuropathy segment is estimated to account for 42.4% revenue share in the global neuropathic pain market by 2016 end.

Request Report TOC @ https://www.persistencemarketresearch.com/toc/4149

On the basis of region, the market has been segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. This report assesses trends driving each market segment and offers analysis and insights into the potential of neuropathic pain in specific regions. North America is estimated to dominate the global neuropathic pain market with maximum value share of the overall market by the end of 2016. The North America neuropathic pain market is estimated to increase at a CAGR of 5.8% through 2024. Emergence of several regional market players, a robust distribution network, and well-developed healthcare infrastructure support in North America are some of the key factors driving revenue growth of the neuropathic pain market in North America.

The global neuropathic pain market report profiles some of the top players operating in the global neuropathic pain market such as Baxter Healthcare Corporation, Depomed, Inc., GlaxoSmithKline PLC, Biogen Idec, Pfizer, Inc., Sanofi S.A., Johnson & Johnson Services, Inc., Eli Lily and Company, and Bristol Myers Squibb. These companies are primarily focusing on producing improved drugs for the treatment of neuropathic pain to gain maximum share in the global neuropathic pain market.

Buy Neuropathic Pain Market Report@ https://www.persistencemarketresearch.com/checkout/4149

 About Us 
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com
Web:www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Neuropathic Pain Market is Appraised to be Valued US$ 8.3 Bn by 2024 End here

News-ID: 818993 • Views:

More Releases from Persistence Market Resarch

Industrial Cable Reels Market is expected to increase by a CAGR of 4.0% by 2031|Key Players are Delachaux SA, Cavotec SA and more
Industrial Cable Reels Market is expected to increase by a CAGR of 4.0% by 2031| …
Trading of modern link pulls in the global market is valued at US$2,480.0 million towards the end of 2018, representing a YoY growth pace of 4.0% north of 2023. In terms of modern link reel volume, China is expected to account for almost 22.2% of the total share of the global modern link reel market towards the end of 2026 and is expected to maintain its position in the modern
Global Market for RTD/high strength premixes is poised to expand at a sub-par CAGR of 4.5% during the forecast period-2026
Global Market for RTD/high strength premixes is poised to expand at a sub-par CA …
Persistence Market Research And new report on the global RTD/high strength premixes market, RTD/High Strength Premixes Market: Global Industry Analysis (2012-2016) and Forecast (2017-2026) The study has been developed to offer valuable insights on how the demand for RTD/high strength premixes will shape up in the immediate future. Industry trends, macroeconomic factors, marketing opportunities, and new applications encompassing the global RTD/high strength premixes market have been analyzed in the report. Market
Food Retail Market Segmented By Food and Grocery Retail, Pet Food Retail in Supermarkets, hypermarkets, Independent and specialist retails, Convenience stores
Food Retail Market Segmented By Food and Grocery Retail, Pet Food Retail in Supe …
Rise in the global population, changing customer preferences and emerging economies are making the way for the food retail industry. It is a dynamically progressing industry and contributes to the development of several industries such as food packaging. Food Retail is categorized under distribution channel into four different segments: supermarkets/hypermarkets, independent and specialist retailers, convenience stores and others. Supermarket or hypermarket segment accounts for a comparatively larger market share. Increasing customer preference
Cosmetic Peptide Synthesis Market Size to Exhibit a US$ 182.1 Mn by 2032 - Insights by Persistence Market Research
Cosmetic Peptide Synthesis Market Size to Exhibit a US$ 182.1 Mn by 2032 - Insig …
The most recent report from Persistence Market Research on the worldwide cosmetic peptide synthesis market assesses the market's opportunities and current state, and it offers in-depth research and the most recent information on the relevant segments that have an impact on the market. The study provides in-depth analysis of the market's present dynamics, including its drivers, constraints, trends, and prospects. The market study's main goal is to provide unique information

All 5 Releases


More Releases for Neuropathy

07-14-2025 | Health & Medicine
Getnews
Neuropathy Care Centers Launches National Push to Rethink Peripheral Neuropathy …
A healthcare organization builds out a collaborative model aimed at earlier intervention and improved patient understanding WHEATON, IL - July 14, 2025 - Neuropathy Care Centers, a Wheaton-based healthcare organization, today announced the expansion of its national initiative to improve how Peripheral Neuropathy is identified and managed across the U.S. The organization is developing a growing network of providers focused on early detection and conservative, nerve-focused care, an effort intended to
Chemotherapy Induced Peripheral Neuropathy Market Trends and Insights, Toward Sa …
Overview of the Market Chemotherapy Induced Peripheral Neuropathy (CIPN) is one of the most common and debilitating side effects of cancer treatment, affecting a significant portion of chemotherapy patients. CIPN occurs when chemotherapy drugs cause damage to the peripheral nerves, leading to symptoms such as numbness, tingling, burning sensations, and pain, primarily in the hands and feet. With the growing global prevalence of cancer, the incidence of CIPN is also rising,
Prominent Diabetic Peripheral Neuropathy Market Trend for 2025: Advancements In …
What industry-specific factors are fueling the growth of the diabetic peripheral neuropathy market? The increase in obesity-related health issues is expected to drive the growth of the diabetic peripheral neuropathy (DPN) market. Obesity, characterized by excessive body fat accumulation, significantly increases the risk of chronic diseases, including type 2 diabetes. This, in turn, heightens the occurrence of diabetic peripheral neuropathy, a complication where high blood sugar levels cause nerve damage. The
Major Market Shift in Peripheral Neuropathy Industry: Technological Advancements …
What Is the Forecasted Market Size and Growth Rate for the Peripheral Neuropathy Market? The size of the peripheral neuropathy market has seen a rapid expansion in recent years, set to increase from $4.09 billion in 2024 to $4.62 billion in 2025, representing a compound annual growth rate (CAGR) of 13.2%. This growth during the historical period is due to a variety of factors including the rising prevalence of chronic illnesses
Combatting Peripheral Neuropathy: Breakthroughs and Beyond
The Business Research Company recently released a comprehensive report on the Global Peripheral Neuropathy Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, the peripheral neuropathy market
Multifocal Motor Neuropathy Market - Progress in nerve restoration: Driving adva …
Newark, New Castle, USA: The "Multifocal Motor Neuropathy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Multifocal Motor Neuropathy Market: https://www.growthplusreports.com/report/multifocal-motor-neuropathy-market/8810 This latest report researches the industry structure,